Abstract
Response to Hasan et al.’s “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.”
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have